Sorrento Therapeutics, Inc.
SRNE
SRNE was delisted on the 22nd of February, 2023.
9 hedge funds and large institutions have $13.9K invested in Sorrento Therapeutics, Inc. in 2023 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 2 closing their positions.
116% more capital invested
Capital invested by funds: $6.42K → $13.9K (+$7.47K)
0% more funds holding
Funds holding: 9 → 9 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LCM
Lattice Capital Management
Kirkland,
Washington
|
+$6.4K |
| 2 |
KA
KLCM Advisors
Milwaukee,
Wisconsin
|
+$1.24K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SW
SlateStone Wealth
Jupiter,
Florida
|
-$1.32K |
| 2 |
HNB
Huntington National Bank
Columbus,
Ohio
|
-$1.24K |
| 3 |
CAS
Coppell Advisory Solutions
Coppell,
Texas
|
-$89 |
| 4 |
Russell Investments Group
London,
United Kingdom
|
-$25 |
SRNE Hedge Fund Activity: Q4 2023 in Review
9 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in Sorrento Therapeutics, Inc. (SRNE) for Q4 2023, worth a combined $13.9K — up 116% from $6.42K a quarter earlier.
Fund positioning in SRNE was balanced in Q4 2023: 2 funds opened new positions, 2 closed out, 1 added to existing stakes and 3 trimmed.
The largest buyer was Lattice Capital Management, opening a new position worth an estimated $6.4K. The largest seller was SlateStone Wealth, cutting an estimated $1.32K.
- 9 institutional investors held Sorrento Therapeutics, Inc. (SRNE) as of Q4 2023, unchanged from Q3 2023.
- Funds reported $13.9K of Sorrento Therapeutics, Inc. stock for Q4 2023, up 116% quarter-over-quarter.
- 2 funds opened new Sorrento Therapeutics, Inc. positions in Q4 2023 and 2 closed out, a net change of 0 holders.
- The largest Sorrento Therapeutics, Inc. buyer in Q4 2023 was Lattice Capital Management, an estimated $6.4K added.
- The largest Sorrento Therapeutics, Inc. seller in Q4 2023 was SlateStone Wealth, an estimated $1.32K sold.
Based on aggregated 13F filings for Q4 2023.